We divided AML patients into two groups of high and low expression according to the median of their respective expression of these five genes, and then analyzed the relationship between different expression status of different genes and different cytogenetic risks, we found that only the expression of SELL was associated with different cytogenetic risks (r = 0.104, P < 0.05) (Table 2). Here, SELL is linked to acute myeloid leukemia.